Beam Therapeutics (BEAM)
(Delayed Data from NSDQ)
$22.93 USD
+1.02 (4.66%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $22.93 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/05/2024
Time: BMO |
9/2024 | $-1.13 | 0.00% |
Earnings Summary
For their last quarter, Beam Therapeutics (BEAM) reported earnings of -$1.11 per share, beating the Zacks Consensus Estimate of $-1.13 per share. This reflects a positive earnings surprise of 1.77%. Look out for BEAM's next earnings release on November 05, 2024. For the next earning release, we expect the company to report earnings of -$1.13 per share, reflecting a year-over-year increase of 7.38%.
Earnings History
Price & Consensus
Zacks News for BEAM
Why Is Beam Therapeutics (BEAM) Down 1.6% Since Last Earnings Report?
BEAM: What are Zacks experts saying now?
Zacks Private Portfolio Services